Overexpression of IRS-4 Correlates with Procaspase 3 Levels in Tumoural Tissue of Patients with Colorectal Cancer

about

Overexpression of IRS-4 Correlates with Procaspase 3 Levels in Tumoural Tissue of Patients with Colorectal Cancer

Item

http://www.wikidata.org/entity/Q58556825

description

scientific article published on 16 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Overexpression of IRS-4 Correl ...... atients with Colorectal Cancer

@en

Overexpression of IRS-4 Correl ...... atients with Colorectal Cancer

@nl

type

Item

label

Overexpression of IRS-4 Correl ...... atients with Colorectal Cancer

@en

Overexpression of IRS-4 Correl ...... atients with Colorectal Cancer

@nl

prefLabel

Overexpression of IRS-4 Correl ...... atients with Colorectal Cancer

@en

Overexpression of IRS-4 Correl ...... atients with Colorectal Cancer

@nl

P1476

Overexpression of IRS-4 Correl ...... atients with Colorectal Cancer

@en

P2093

Luis G Guijarro

http://www.w3.org/2001/XMLSchema#string

Patricia Sanmartín-Salinas

http://www.w3.org/2001/XMLSchema#string

P2860

Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling

The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy

Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation

Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade

Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration

Interaction between Brk kinase and insulin receptor substrate-4.

Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer

Effect of IRS4 levels on PI 3-kinase signalling.

PTK6 regulates IGF-1-induced anchorage-independent survival.

Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy

P304

3812581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/3812581

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Patricia Sanmartín-Salinas

Luis G Guijarro

P577

2018-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30410539

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

overexpression

P932

6206579

http://www.w3.org/2001/XMLSchema#string